BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 22447879)

  • 1. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.
    Endo S; Yano H; Hirakata Y; Arai K; Kanamori H; Ogawa M; Shimojima M; Ishibashi N; Aoyagi T; Hatta M; Yamada M; Tokuda K; Kitagawa M; Kunishima H; Kaku M
    J Antimicrob Chemother; 2012 Jul; 67(7):1623-6. PubMed ID: 22447879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
    Manageiro V; Jones-Dias D; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2012 Nov; 40(5):398-403. PubMed ID: 22890192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09).
    Gogou V; Pournaras S; Giannouli M; Voulgari E; Piperaki ET; Zarrilli R; Tsakris A
    J Antimicrob Chemother; 2011 Dec; 66(12):2767-72. PubMed ID: 21933784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
    Amudhan SM; Sekar U; Arunagiri K; Sekar B
    Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
    Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
    J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.
    Ruan Z; Chen Y; Jiang Y; Zhou H; Zhou Z; Fu Y; Wang H; Wang Y; Yu Y
    Int J Antimicrob Agents; 2013 Oct; 42(4):322-8. PubMed ID: 23988720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
    Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
    Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
    Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
    Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
    Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
    J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
    Kouyama Y; Harada S; Ishii Y; Saga T; Yoshizumi A; Tateda K; Yamaguchi K
    J Infect Chemother; 2012 Aug; 18(4):522-8. PubMed ID: 22327516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLST analysis of multiple antimicrobial resistant Acinetobacter baumannii.
    Yasuhara T; Kugawa S; Tateishi Y; Ugajin K; Yoshida K; Fukuchi K
    Rinsho Byori; 2013 Jun; 61(6):488-92. PubMed ID: 23947186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate.
    Nigro SJ; Hall RM
    J Antimicrob Chemother; 2012 Jun; 67(6):1342-6. PubMed ID: 22351684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.